Skip to main content
Premium Trial:

Request an Annual Quote

Promega OncoMate MSI

Promega Corporation has launched the OncoMate MSI Dx Analysis System in the US. The in vitro diagnostic was cleared by the US Food and Drug Administration last month as an IVD medical device and gives oncologists and pathologists a new option to screen for Lynch syndrome in patients with colorectal cancer by determining microsatellite instability (MSI) status in their tumors.

Promega said it's underlying MSI technology has been in use for more than 15 years and is supported by over 140 peer-reviewed publications.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.